Finished
Assessment of Clin. Capabilities of LIBERTY® Endovascular Robotic System's Performance & Safety in Periph. Vasc. Interv.
NCT06141694 · Microbot Medical, INC · Updated 17 Oct 2024
- What is being tested
- The LIBERTY® Robotic System
- For
- Peripheral Vascular Interventions
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 22 years to 80 years. About 20 people. The full rules are on the registry page.
- Where
- United States (3 sites)
- When
- Starts or started 2 July 2024, ends 15 Oct 2024. Registered 21 Nov 2023.
- Results
- None posted yet.
In the researchers' words
A prospective, multi-center, single-arm, study to evaluate the performance and safety of the LIBERTY® Robotic System in human subjects undergoing Peripheral Vascular Interventions. The study is designed to evaluate the performance and safety of endovascular procedures supported by the LIBERTY® Robotic System. The System is configured to deliver and manipulate third-party commercially available surgical devices that are employed in endovascular transcatheter procedures (guidewires, microcatheters, and guiding catheters).
Sites
- Baptist Hospital of MiamiMiami, Florida, United States
- Brigham and Women's HospitalBoston, Massachusetts, United States
- Memorial Sloan Kettering Cancer CenterNew York, New York, United States